FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Clinical trials for FAMILIAL ADENOMATOUS POLYPOSIS (FAP) explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL ADENOMATOUS POLYPOSIS (FAP) trials appear
Sign up with your email to follow new studies for FAMILIAL ADENOMATOUS POLYPOSIS (FAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug FOG-001 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug, FOG-001, in about 595 people with advanced or metastatic solid tumors, including colorectal, prostate, and liver cancers. The drug is given alone or with other cancer treatments to see if it is safe and shrinks tumors. The study is cu…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Rapamycin formulation offers hope for rare polyp disorder
Disease control AVAILABLEThis expanded access program provides eRapa, an oral encapsulated form of rapamycin, to people with familial adenomatous polyposis (FAP) who have no good treatment options and cannot join a clinical trial. FAP causes hundreds of polyps in the colon and rectum, raising cancer risk…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Sponsor: Biodexa Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug eRapa could slow polyps in inherited colon cancer condition
Disease control Recruiting nowThis study tests if the drug eRapa can slow disease progression in adults with Familial Adenomatous Polyposis (FAP), a condition that causes many polyps in the gut and raises cancer risk. About 168 participants will take eRapa or a placebo daily every other week. Researchers will…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Phase: PHASE3 • Sponsor: Rapamycin Holdings Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Which scope method spots precancerous polyps best in FAP pouches? a head-to-head trial aims to find out.
Knowledge-focused Recruiting nowThis trial compares two ways of inspecting the ileo-anal pouch during routine surveillance in adults with familial adenomatous polyposis (FAP): dye-based chromoendoscopy (spraying a blue dye) versus virtual chromoendoscopy (using special light filters). The goal is to see which t…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
Phase: NA • Sponsor: London North West Healthcare NHS Trust • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC